Gross Margin
17.19%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 10.59%.Updated Aug 21, 2026Profit Margin
-5.29%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Margin
4.41%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Assets (TTM)
-1.11%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Equity (TTM)
-7.10%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue (TTM)
846.94MCNY125.95M · vs all stocks (USD) Updated Aug 21, 2026Revenue per Share (TTM)
1.48CNYUpdated Aug 21, 2026Quarterly Revenue Growth
48.80%vs Specialty Chemicals peers Updated Aug 21, 2026Gross Profit (TTM)
89.66MCNY13.33M · vs all stocks (USD) Updated Aug 21, 2026EBITDA (TTM)
63.67MCNY9.47M · vs all stocks (USD) Updated Aug 21, 2026Net Income (TTM)
-44.78MCNY-6.66M · vs all stocks (USD) Updated Aug 21, 2026Quarterly Earnings Growth (YoY)
339.20%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Cash Flow (TTM)
-109.08MCNY-16.22M · vs all stocks (USD) Updated Aug 21, 2026Levered Free Cash Flow (TTM)
-149.89MCNY-22.29M · vs all stocks (USD) Updated Aug 21, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 21, 2026Minority Interest (Equity)
-60.95MCNYFY2025 · Dec 31, 2025Revenue
762.13MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
677.82MCNYFY2025 · Dec 31, 2025Gross Profit
84.30MCNYFY2025 · Dec 31, 2025Operating Income
-31.00MCNY-4.61M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-61.47MCNYFY2025 · Dec 31, 2025Income Tax Expense
-2.73MCNYFY2025 · Dec 31, 2025Net Income
-58.74MCNYFY2025 · Dec 31, 2025EBIT
-48.59MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
63.67MCNYFY2025 · Dec 31, 2025Research & Development
23.30MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
26.35MCNYFY2025 · Dec 31, 2025Other Operating Expenses
13.46MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
410.45KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
12.88MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0975CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0975CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
570.03MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
570.03MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-58.74MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.16MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-228.91MCNYFY2025 · Dec 31, 2025Free Cash Flow
-241.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
28.22MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-58.74MCNYFY2025 · Dec 31, 2025Other Non-cash Items
15.25MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-91.96MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-93.46MCNYFY2025 · Dec 31, 2025Capital Expenditures
-12.42MCNYFY2025 · Dec 31, 2025Net Acquisitions
71.74MCNYFY2025 · Dec 31, 2025Purchase of Investments
-8.51MCNYFY2025 · Dec 31, 2025Sale of Investments
3.53MCNYFY2025 · Dec 31, 2025Other Investing Activity
-4.51MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
49.83MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
334.48MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-164.31MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-10.05MCNYFY2025 · Dec 31, 2025Other Financing Charges
-57.06MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
103.06MCNYFY2025 · Dec 31, 2025